25 July 2022
Freshfields Advises Zymergen on its Sale to Ginkgo Bioworks — First-Ever Sale of a Publicly-Listed Public Benefit Corporation
Advising firms
Deal team
30 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Joseph Halloum Lead | Freshfields | Partner | M&A | Not stated |
| Sarah Solum Lead | Freshfields | Partner | capital markets | Not stated |
| Oliver Board | Freshfields | Counsel | M&A | Not stated |
| Victor Ma | Freshfields | Associate | M&A | Not stated |
| Joyce Yeo | Freshfields | Associate | M&A | Not stated |
| Jenny Park | Freshfields | Associate | M&A | Not stated |
| Wicy Wang | Freshfields | Associate | M&A | Not stated |
| Lori Goodman | Freshfields | Partner | executive compensation and employee benefits | Not stated |
| Sarah Ghulamhussain | Freshfields | Counsel | executive compensation and employee benefits | Not stated |
| Lina Zhu | Freshfields | Associate | executive compensation and employee benefits | Not stated |
| Justin Stewart-Teitelbaum | Freshfields | Partner | antitrust | Not stated |
| Angela Landry | Freshfields | Counsel | antitrust | Not stated |
| Lauren Vaca | Freshfields | Associate | antitrust | Not stated |
| Claude Stansbury | Freshfields | Partner | tax | Not stated |
| David Mitchell | Freshfields | Senior associate | tax | Not stated |
| Mena Kaplan | Freshfields | Partner | IP/tech transactions | Not stated |
| Marissa Yu | Freshfields | Associate | IP/tech transactions | Not stated |
| Mili Astesiano | Freshfields | Associate | IP/tech transactions | Not stated |
| Christine Lyon | Freshfields | Partner | data privacy and security | Not stated |
| Brock Dahl | Freshfields | Counsel | data privacy and security | Not stated |
| Cody Goodchild | Freshfields | Associate | data privacy and security | Not stated |
| Aimen Mir | Freshfields | Partner | foreign investment/trade compliance | Not stated |
| Nabeel Yousef | Freshfields | Partner | foreign investment/trade compliance | Not stated |
| Amy Cattle | Freshfields | Senior associate | foreign investment/trade compliance | Not stated |
| Vinita Kailasanath | Freshfields | Partner | life sciences | Not stated |
| Sora Park | Freshfields | Associate | life sciences | Not stated |
| Boris Feldman | Freshfields | Partner | litigation | Not stated |
| Meredith Kotler | Freshfields | Partner | litigation | Not stated |
| Doru Gavril | Freshfields | Partner | litigation | Not stated |
| Drew Liming | Freshfields | Senior associate | litigation | Not stated |
Stated terms
- Stated value
- USD 300m (approximately $300 million)
- What the figure measures
- Total transaction value
- Client
- Zymergen Inc.Sell-side
- Counterparties
- Ginkgo Bioworks Holdings, Inc. (Buy-side)